pharma packing lines limited Company Information
Company Number
07174297
Website
-Registered Address
3 winterfold court, barhatch lane, cranleigh, surrey, GU6 7NH
Industry
Manufacture of other special-purpose machinery n.e.c.
Telephone
-
Next Accounts Due
December 2024
Group Structure
View All
Directors
Catharine McGuire14 Years
Shareholders
catharine mcguire 100%
pharma packing lines limited Estimated Valuation
Pomanda estimates the enterprise value of PHARMA PACKING LINES LIMITED at £0 based on a Turnover of £0 and 0.54x industry multiple (adjusted for size and gross margin).
pharma packing lines limited Estimated Valuation
Pomanda estimates the enterprise value of PHARMA PACKING LINES LIMITED at £0 based on an EBITDA of £0 and a 4.32x industry multiple (adjusted for size and gross margin).
pharma packing lines limited Estimated Valuation
Pomanda estimates the enterprise value of PHARMA PACKING LINES LIMITED at £44.7k based on Net Assets of £21.9k and 2.04x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pharma Packing Lines Limited Overview
Pharma Packing Lines Limited is a live company located in cranleigh, GU6 7NH with a Companies House number of 07174297. It operates in the manufacture of other special-purpose machinery n.e.c. sector, SIC Code 28990. Founded in March 2010, it's largest shareholder is catharine mcguire with a 100% stake. Pharma Packing Lines Limited is a established, unknown sized company, Pomanda has estimated its turnover at £0 with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Pharma Packing Lines Limited Health Check
Pomanda's financial health check has awarded Pharma Packing Lines Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 2 areas for improvement. Company Health Check FAQs
2 Strong
0 Regular
2 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Pharma Packing Lines Limited
- - Industry AVG
Growth
3 year (CAGR) sales growth of -100%, show it is growing at a slower rate (2.1%)
- Pharma Packing Lines Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Pharma Packing Lines Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Pharma Packing Lines Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (65)
- Pharma Packing Lines Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Pharma Packing Lines Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Pharma Packing Lines Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Pharma Packing Lines Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Pharma Packing Lines Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Pharma Packing Lines Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 127 weeks, this is more cash available to meet short term requirements (14 weeks)
- - Pharma Packing Lines Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 40.9%, this is a lower level of debt than the average (48.8%)
- - Pharma Packing Lines Limited
- - Industry AVG
PHARMA PACKING LINES LIMITED financials
Pharma Packing Lines Limited's latest turnover from March 2023 is 0 and the company has net assets of £21.9 thousand. According to their latest financial statements, we estimate that Pharma Packing Lines Limited has 1 employee and maintains cash reserves of £37 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 0 | 0 | |||||||||||
Other Income Or Grants | 0 | 0 | |||||||||||
Cost Of Sales | 0 | 0 | |||||||||||
Gross Profit | 0 | 0 | |||||||||||
Admin Expenses | 0 | 0 | |||||||||||
Operating Profit | 0 | 0 | |||||||||||
Interest Payable | 0 | 0 | |||||||||||
Interest Receivable | 0 | 0 | |||||||||||
Pre-Tax Profit | 0 | 0 | |||||||||||
Tax | 0 | 0 | |||||||||||
Profit After Tax | 0 | 0 | |||||||||||
Dividends Paid | 0 | 0 | |||||||||||
Retained Profit | 0 | 0 | |||||||||||
Employee Costs | 0 | 0 | |||||||||||
Number Of Employees | 1 | 1 | 1 | 1 | |||||||||
EBITDA* | 0 | 0 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 364 | 3,250 | 6,136 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 364 | 3,250 | 6,136 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 0 | 7,726 | 41,310 | 27,127 | 43,241 | 37,410 | 55,022 | 26,635 | 542 | 436 | 0 | 59,664 | 0 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 37,040 | 32,027 | 0 | 0 | 0 | 0 | 0 | 0 | 9,061 | 27,711 | 10,877 | 5,887 | 18,974 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 29 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 37,040 | 39,753 | 41,310 | 27,127 | 43,241 | 37,410 | 55,051 | 26,635 | 9,603 | 28,147 | 10,877 | 65,551 | 18,974 |
total assets | 37,040 | 39,753 | 41,310 | 27,127 | 43,241 | 37,410 | 55,051 | 26,637 | 9,605 | 28,149 | 11,241 | 68,801 | 25,110 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 15,150 | 17,862 | 18,622 | 6,117 | 12,387 | 10,283 | 23,978 | 27,400 | 10,404 | 29,391 | 12,719 | 66,146 | 20,506 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 15,150 | 17,862 | 18,622 | 6,117 | 12,387 | 10,283 | 23,978 | 27,400 | 10,404 | 29,391 | 12,719 | 66,146 | 20,506 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 870 | 840 | 9,840 | 6,840 | 10,840 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 870 | 840 | 9,840 | 6,840 | 10,840 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 15,150 | 17,862 | 19,492 | 6,957 | 22,227 | 17,123 | 34,818 | 27,400 | 10,404 | 29,391 | 12,719 | 66,146 | 20,506 |
net assets | 21,890 | 21,891 | 21,818 | 20,170 | 21,014 | 20,287 | 20,233 | -763 | -799 | -1,242 | -1,478 | 2,655 | 4,604 |
total shareholders funds | 21,890 | 21,891 | 21,818 | 20,170 | 21,014 | 20,287 | 20,233 | -763 | -799 | -1,242 | -1,478 | 2,655 | 4,604 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||
Operating Profit | 0 | 0 | |||||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 362 | 2,886 | 2,886 | 2,525 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | 0 | 0 | |||||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | -7,726 | -33,584 | 14,183 | -16,114 | 5,831 | -17,612 | 28,387 | 26,093 | 106 | 436 | -59,664 | 59,664 | 0 |
Creditors | -2,712 | -760 | 12,505 | -6,270 | 2,104 | -13,695 | -3,422 | 16,996 | -18,987 | 16,672 | -53,427 | 45,640 | 20,506 |
Accruals and Deferred Income | 0 | -870 | 30 | -9,000 | 3,000 | -4,000 | 10,840 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | 5,014 | 31,954 | |||||||||||
Investing Activities | |||||||||||||
capital expenditure | |||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||
Financing Activities | |||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||||
interest | 0 | 0 | |||||||||||
cash flow from financing | -1 | 73 | |||||||||||
cash and cash equivalents | |||||||||||||
cash | 5,013 | 32,027 | 0 | 0 | 0 | 0 | 0 | -9,061 | -18,650 | 16,834 | 4,990 | -13,087 | 18,974 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 5,013 | 32,027 | 0 | 0 | 0 | 0 | 0 | -9,061 | -18,650 | 16,834 | 4,990 | -13,087 | 18,974 |
pharma packing lines limited Credit Report and Business Information
Pharma Packing Lines Limited Competitor Analysis
Perform a competitor analysis for pharma packing lines limited by selecting its closest rivals, whether from the MANUFACTURING sector, other established companies, companies in GU6 area or any other competitors across 12 key performance metrics.
pharma packing lines limited Ownership
PHARMA PACKING LINES LIMITED group structure
Pharma Packing Lines Limited has no subsidiary companies.
Ultimate parent company
PHARMA PACKING LINES LIMITED
07174297
pharma packing lines limited directors
Pharma Packing Lines Limited currently has 1 director, Ms Catharine McGuire serving since Mar 2010.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Ms Catharine McGuire | United Kingdom | 63 years | Mar 2010 | - | Director |
P&L
March 2023turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
21.9k
0%
total assets
37k
-0.07%
cash
37k
+0.16%
net assets
Total assets minus all liabilities
pharma packing lines limited company details
company number
07174297
Type
Private limited with Share Capital
industry
28990 - Manufacture of other special-purpose machinery n.e.c.
incorporation date
March 2010
age
14
incorporated
UK
ultimate parent company
accounts
Dormant
last accounts submitted
March 2023
previous names
N/A
accountant
JACKIE BONELLA
auditor
-
address
3 winterfold court, barhatch lane, cranleigh, surrey, GU6 7NH
Bank
HSBC BANK PLC
Legal Advisor
-
pharma packing lines limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to pharma packing lines limited.
pharma packing lines limited Companies House Filings - See Documents
date | description | view/download |
---|